Top

International Journal of Clinical Oncology

Published in:

Open Access 01-04-2020 | Spinal Metastasis | Original Article

Research on the predicting power of the revised Tokuhashi system: how much time can surgery give to patients with short life expectancy?

Authors: Tamás Mezei, Anna Horváth, Péter Pollner, Gábor Czigléczki, Péter Banczerowski

Published in: International Journal of Clinical Oncology | Issue 4/2020

Abstract

Object

The primary treatment option for symptomatic metastatic spinal tumors is surgery. Prognostic systems are designed to assist in the establishment of the indication and the choice of surgical methodology. The best-known prognostic system is the revised Tokuhashi system, which has a predictive ability of about 60%. In our study, we are attempting to find the reason for its poor predictive ability, despite its proper separation ability.

Methods

We have designed a one-center-based retrospective clinical trial, by which we would like to test the feasibility and the inaccuracy of the revised Tokuhashi system. In our database, there are 329 patients who underwent surgery. Statistical analysis was performed.

Results

A significant increase in survival time was observed in the ‘conservative’ category. Earlier studies reported OS 0.15 at the 180-day control time, in contrast with our 0.38 OS value. The literature suggested supportive care for this category, but in our population, every patient underwent surgery. Our population passes the 0.15 OS value on day 475. We propose an adjustment of the Tokuhashi category scores. We observed significant success in resolving pain. Motor functions were improved or stabilized compared to changes in vegetative dysfunction.

Conclusion

According to our results, the Tokuhashi scoring system makes very conservative predictions and prefers non-surgical palliative or supportive care. Surgical treatment increases the life expectancy of patients in poor condition. We propose modifying the therapeutic options of the revised Tokuhashi system, taking into consideration modern spine surgery techniques.

Schulman KL, Kohles J (2007) Economic burden of metastatic bone disease in the US. Cancer 109 (11):2334–2342. 10.1002/cncr.22678

Hernandez RK, Wade SW, Reich A et al (2018) Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the US. BMC Cancer 18(1):44. https://doi.org/10.1186/s12885-017-3922-0 CrossRefPubMedPubMedCentral

Patchell RA, Tibbs PA, Regine WF et al (2005) Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 366(9486):643–648. https://doi.org/10.1016/S0140-6736(05)66954-1 CrossRefPubMed

Yao A, Sarkiss CA, Ladner TR et al (2017) Contemporary spinal oncology treatment paradigms and outcomes for metastatic tumors to the spine: a systematic review of breast, prostate, renal, and lung metastases. J Clin Neurosci 41:11–23. https://doi.org/10.1016/j.jocn.2017.04.004 CrossRefPubMed

Ecker RD, Endo T, Wetjen NM et al (2005) Diagnosis and treatment of vertebral column metastases. Mayo Clin Proc 80(9):1177–1186. https://doi.org/10.4065/80.9.1177 CrossRefPubMed

Choi D, Bilsky M, Fehlings M et al (2017) Spine oncology-metastatic spine tumors. Neurosurgery 80(3S):S131–S137. https://doi.org/10.1093/neuros/nyw084 CrossRefPubMed

Kaloostian PE, Yurter A, Etame AB et al (2014) Palliative strategies for the management of primary and metastatic spinal tumors. Cancer Control 21(2):140–143. https://doi.org/10.1177/107327481402100206 CrossRefPubMed

Choi D, Fox Z, Albert T, et al. (2015) Prediction of quality of life and survival after surgery for symptomatic spinal metastases: a multicenter cohort study to determine suitability for surgical treatment. Neurosurgery 77(5):698–708 (discussion 708). 10.1227/NEU.0000000000000907

Tokuhashi Y, Matsuzaki H, Oda H, et al. (2005) A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976) 30(19):2186–2191

10.

Luksanapruksa P, Buchowski JM, Hotchkiss W et al (2016) Prognostic factors in patients with spinal metastasis: a systematic review and meta-analysis. Spine J. https://doi.org/10.1016/j.spinee.2016.12.003 CrossRefPubMed

11.

Quraishi NA, Manoharan SR, Arealis G et al (2013) Accuracy of the revised Tokuhashi score in predicting survival in patients with metastatic spinal cord compression (MSCC). Eur Spine J 22(Suppl 1):S21–26. https://doi.org/10.1007/s00586-012-2649-5 CrossRefPubMed

12.

Bollen L, Wibmer C, Van der Linden YM, et al. (2016) Predictive value of six prognostic scoring systems for spinal bone metastases: an analysis based on 1379 patients. Spine (Phila Pa 1976) 41(3):E155–162. 10.1097/BRS.0000000000001192

13.

Tokuhashi Y, Kawano H, Ohsaka S et al (1989) A scoring system for preoperative evaluation of the prognosis of metastatic spine tumor (a preliminary report). Nihon Seikeigeka Gakkai Zasshi 63(5):482–489PubMed

14.

Czigleczki G, Mezei T, Pollner P et al (2018) Prognostic factors of surgical complications and overall survival of patients with metastatic spinal tumor. World Neurosurg 113:e20–e28. https://doi.org/10.1016/j.wneu.2018.01.092 CrossRefPubMed

15.

Pollner P, Horvath A, Mezei T et al (2018) Analysis of four scoring systems for the prognosis of patients with metastasis of the vertebral column. World Neurosurg 112:e675–e682. https://doi.org/10.1016/j.wneu.2018.01.124 CrossRefPubMed

16.

Kirkinis MN, Lyne CJ, Wilson MD et al (2016) Metastatic bone disease: a review of survival, prognostic factors and outcomes following surgical treatment of the appendicular skeleton. Eur J Surg Oncol 42(12):1787–1797. https://doi.org/10.1016/j.ejso.2016.03.036 CrossRefPubMed

17.

Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996. https://doi.org/10.1056/NEJMoa043330 CrossRefPubMed

18.

Rades D, Conde-Moreno AJ, Cacicedo J et al (2018) A scoring system to predict local progression-free survival in patients irradiated with 20 Gy in 5 fractions for malignant spinal cord compression. Radiat Oncol 13(1):257. https://doi.org/10.1186/s13014-018-1203-y CrossRefPubMedPubMedCentral

19.

da Silva GT, Bergmann A, Thuler LCS (2017) Impact of symptomatic metastatic spinal cord compression on survival of patients with non-small-cell lung cancer. World Neurosurg 108:698–704. https://doi.org/10.1016/j.wneu.2017.09.079 CrossRefPubMed

20.

Tokuhashi Y, Uei H, Oshima M et al (2014) Scoring system for prediction of metastatic spine tumor prognosis. World J Orthop 5(3):262–271. https://doi.org/10.5312/wjo.v5.i3.262 CrossRefPubMedPubMedCentral

21.

Cassidy JT, Baker JF, Lenehan B (2018) The role of prognostic scoring systems in assessing surgical candidacy for patients with vertebral metastasis: a narrative review. Global Spine J 8(6):638–651. https://doi.org/10.1177/2192568217750125 CrossRefPubMedPubMedCentral

22.

Choi D, Ricciardi F, Arts M, et al. (2018) Prediction accuracy of common prognostic scoring systems for metastatic spine disease: results of a prospective international multicentre study of 1469 patients. Spine (Phila Pa 1976) 43(23):1678–1684. 10.1097/BRS.0000000000002576

23.

Zoccali C, Skoch J, Walter CM et al (2016) The Tokuhashi score: effectiveness and pitfalls. Eur Spine J 25(3):673–678. https://doi.org/10.1007/s00586-015-4339-6 CrossRefPubMed

24.

Pelegrini de Almeida L, Vidaletti T, de Lima M et al (2018) Reliability of tokuhashi score to predict prognosis: comparison of 117 patients. World Neurosurg 111:e1–e6. https://doi.org/10.1016/j.wneu.2017.11.033 CrossRefPubMed

25.

Oliveira MF, Barros Bde A, Rotta JM et al (2013) Tokuhashi scoring system has limited applicability in the majority of patients with spinal cord compression secondary to vertebral metastasis. Arq Neuropsiquiatr 71(10):798–801. https://doi.org/10.1590/0004-282X20130125 CrossRefPubMed

26.

Bollen L, Jacobs WCH, Van der Linden YM et al (2018) A systematic review of prognostic factors predicting survival in patients with spinal bone metastases. Eur Spine J 27(4):799–805. https://doi.org/10.1007/s00586-017-5320-3 CrossRefPubMed

27.

Uei H, Tokuhashi Y (2018) Prognostic factors in patients with metastatic spine tumors derived from lung cancer-a novel scoring system for predicting life expectancy. World J Surg Oncol 16(1):131. https://doi.org/10.1186/s12957-018-1439-x CrossRefPubMedPubMedCentral

28.

Barzilai O, McLaughlin L, Amato MK et al (2018) Minimal access surgery for spinal metastases: prospective evaluation of a treatment algorithm using patient-reported outcomes. World Neurosurg 120:e889–e901. https://doi.org/10.1016/j.wneu.2018.08.182 CrossRefPubMedPubMedCentral

29.

Gu Y, Dong J, Jiang X, et al. (2016) Minimally invasive pedicle screws fixation and percutaneous vertebroplasty for the surgical treatment of thoracic metastatic tumors with neurologic compression. Spine (Phila Pa 1976) 41(Suppl 19):B14–B22. 10.1097/BRS.0000000000001811

30.

Banczerowski P, Czigleczki G, Papp Z, et al. (2015) Minimally invasive spine surgery: systematic review. Neurosurg Rev 38(1):11–26; (discussion 26). 10.1007/s10143–014–0565–3

31.

Tang Y, Qu J, Wu J et al (2016) Effect of surgery on quality of life of patients with spinal metastasis from non-small-cell lung cancer. J Bone Jt Surg Am 98(5):396–402. https://doi.org/10.2106/JBJS.O.00629 CrossRef

32.

Miyazaki S, Kakutani K, Sakai Y et al (2017) Quality of life and cost-utility of surgical treatment for patients with spinal metastases: prospective cohort study. Int Orthop 41(6):1265–1271. https://doi.org/10.1007/s00264-017-3463-9 CrossRefPubMed

33.

de Ruiter GC, Nogarede CO, Wolfs JF et al (2017) Quality of life after different surgical procedures for the treatment of spinal metastases: results of a single-center prospective case series. Neurosurg Focus 42(1):E17. https://doi.org/10.3171/2016.6.FOCUS16150 CrossRefPubMed

34.

Rao PJ, Thayaparan GK, Fairhall JM et al (2014) Minimally invasive percutaneous fixation techniques for metastatic spinal disease. Orthop Surg 6(3):187–195. https://doi.org/10.1111/os.12114 CrossRefPubMedPubMedCentral

Title: Research on the predicting power of the revised Tokuhashi system: how much time can surgery give to patients with short life expectancy?
Authors: Tamás Mezei
Anna Horváth
Péter Pollner
Gábor Czigléczki
Péter Banczerowski
Publication date: 01-04-2020
Publisher: Springer Singapore
Keyword: Spinal Metastasis
Published in: International Journal of Clinical Oncology / Issue 4/2020
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI: https://doi.org/10.1007/s10147-019-01612-w

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Object

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2020

Long-term outcomes of multimodal therapy combining definitive chemoradiotherapy and salvage surgery for T4 esophageal squamous cell carcinoma

Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei

Significance of RAS mutations in pulmonary metastases of patients with colorectal cancer

LINC00163 inhibits the invasion and metastasis of gastric cancer cells as a ceRNA by sponging miR-183 to regulate the expression of AKAP12

Association of employment and company size with lung cancer screening participation among Japanese based on the socioeconomic conditions using the Comprehensive Survey of Living Conditions

Preoperative lymphocyte-to-monocyte ratio predicts postoperative infectious complications after laparoscopic colorectal cancer surgery

Keynote webinar | Spotlight on antibody–drug conjugates in cancer